Precipio Diagnostics: Funding, Investors & Team (Oct 2026)
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis.
Precipio Diagnostics has raised $500k across 1 funding round on record, the most recent an undisclosed round of $500k announced in May 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Precipio Diagnostics Company Profile and Key Stats
Latest funding round on record: May 2024.
Precipio Diagnostics Funding Rounds
Precipio Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Precipio Diagnostics Funding Compared to Other Biotechnology Startups
Precipio Diagnostics' latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Precipio Diagnostics in Biotechnology and New Haven
Companies Similar to Precipio Diagnostics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Precipio Diagnostics Funding FAQs
What does Precipio Diagnostics do?
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis.
How much funding has Precipio Diagnostics raised?
Precipio Diagnostics has raised $500k across 1 round on record. The most recent is an undisclosed round of $500k announced in May 2024.
When did Precipio Diagnostics last raise funding?
Precipio Diagnostics' most recent funding round on record is an undisclosed round of $500k, announced in May 2024.
Who founded Precipio Diagnostics?
FundedIQ lists Ilan Danieli (Founder) at Precipio Diagnostics.
Where is Precipio Diagnostics headquartered?
Precipio Diagnostics is based in New Haven, Connecticut, United States.
How many employees does Precipio Diagnostics have?
Precipio Diagnostics is in the 51-100 employee band.
How does Precipio Diagnostics' funding compare to other Biotechnology startups?
Precipio Diagnostics' latest round of $500k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Precipio Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Precipio Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.